ID22414A - THE USE OF QUINOXOXINE IN A TRIPEL COMBINATION WITH OBSTACLES OF PROTEASE AND OBSTACLES OF BEHIND TRANSCRYPTAGE AS A MEDICINE FOR TREATMENT OF AIDS AND / OR HIV INFECTION - Google Patents

THE USE OF QUINOXOXINE IN A TRIPEL COMBINATION WITH OBSTACLES OF PROTEASE AND OBSTACLES OF BEHIND TRANSCRYPTAGE AS A MEDICINE FOR TREATMENT OF AIDS AND / OR HIV INFECTION

Info

Publication number
ID22414A
ID22414A IDW990759A ID990759A ID22414A ID 22414 A ID22414 A ID 22414A ID W990759 A IDW990759 A ID W990759A ID 990759 A ID990759 A ID 990759A ID 22414 A ID22414 A ID 22414A
Authority
ID
Indonesia
Prior art keywords
obstacles
transcryptage
quinoxoxine
tripel
protease
Prior art date
Application number
IDW990759A
Other languages
Indonesian (id)
Inventor
Arnold Paessens
Martin Blunck
Gunter Riess
Jorg-Peter Kleim
Manfred Rosner
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ID22414A publication Critical patent/ID22414A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW990759A 1997-01-29 1998-01-15 THE USE OF QUINOXOXINE IN A TRIPEL COMBINATION WITH OBSTACLES OF PROTEASE AND OBSTACLES OF BEHIND TRANSCRYPTAGE AS A MEDICINE FOR TREATMENT OF AIDS AND / OR HIV INFECTION ID22414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19703131A DE19703131A1 (en) 1997-01-29 1997-01-29 Use of quinoxaline in a combination of three with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of AIDS and / or HIV infections

Publications (1)

Publication Number Publication Date
ID22414A true ID22414A (en) 1999-10-14

Family

ID=7818634

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990759A ID22414A (en) 1997-01-29 1998-01-15 THE USE OF QUINOXOXINE IN A TRIPEL COMBINATION WITH OBSTACLES OF PROTEASE AND OBSTACLES OF BEHIND TRANSCRYPTAGE AS A MEDICINE FOR TREATMENT OF AIDS AND / OR HIV INFECTION

Country Status (16)

Country Link
EP (1) EP0977570A1 (en)
JP (1) JP2001511124A (en)
KR (1) KR20000070543A (en)
CN (1) CN1251525A (en)
AR (1) AR011094A1 (en)
AU (1) AU6094098A (en)
BR (1) BR9807523A (en)
CA (1) CA2278773A1 (en)
DE (1) DE19703131A1 (en)
ID (1) ID22414A (en)
IL (1) IL130877A0 (en)
NO (1) NO993670L (en)
PL (1) PL334770A1 (en)
SK (1) SK99899A3 (en)
WO (1) WO1998032442A1 (en)
ZA (1) ZA98679B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2374198A1 (en) * 1998-05-29 1999-12-02 Maki Arai Combination therapy for treatment of fiv infection
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
AU6329599A (en) * 1998-09-28 2000-04-17 Glaxo Group Limited Antiviral combinations comprising (s)-2-ethyl -7-fluoro -3-oxo-3, 4-dihydro -2h-quinoxaline -1-carboxylic acid isopropyl ester
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
SE9902987D0 (en) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (en) 2000-02-25 2003-07-31 Astrazeneca Ab HETEROCICLIOCS CONTAINING NITROGEN, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
AR028948A1 (en) 2000-06-20 2003-05-28 Astrazeneca Ab NEW COMPOUNDS
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (en) 2001-03-19 2004-05-05 Astrazeneca Ab BENCIMIDAZOL COMPOUNDS, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION, AND USES OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (en) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (en) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (en) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
CA2633400A1 (en) * 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl urea for treating virus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT509398E (en) * 1991-04-15 2002-02-28 Aventis Pharma Gmbh QUINOXALINES PROCESS FOR THEIR PREPARATION AND ITS UTILIZATION
DE4342024A1 (en) * 1993-12-09 1995-06-14 Hoechst Ag Combination preparations containing a quinoxaline and a nucleoside
DE19506742A1 (en) * 1995-02-27 1996-08-29 Bayer Ag Use of quinoxalines in combination with protease inhibitors as medicaments for the treatment of AIDS and / or HIV infections

Also Published As

Publication number Publication date
EP0977570A1 (en) 2000-02-09
IL130877A0 (en) 2001-01-28
SK99899A3 (en) 2000-03-13
NO993670D0 (en) 1999-07-28
AR011094A1 (en) 2000-08-02
CA2278773A1 (en) 1998-07-30
DE19703131A1 (en) 1998-07-30
WO1998032442A1 (en) 1998-07-30
BR9807523A (en) 2000-03-21
PL334770A1 (en) 2000-03-13
ZA98679B (en) 1998-08-05
KR20000070543A (en) 2000-11-25
AU6094098A (en) 1998-08-18
NO993670L (en) 1999-09-10
CN1251525A (en) 2000-04-26
JP2001511124A (en) 2001-08-07

Similar Documents

Publication Publication Date Title
ID22414A (en) THE USE OF QUINOXOXINE IN A TRIPEL COMBINATION WITH OBSTACLES OF PROTEASE AND OBSTACLES OF BEHIND TRANSCRYPTAGE AS A MEDICINE FOR TREATMENT OF AIDS AND / OR HIV INFECTION
FI955315A7 (en) HIV protease inhibitors useful in the treatment of AIDS
AU775126C (en) Substituted oxazolidinones and their use in the field of blood coagulation
FI955509A7 (en) Ribozyme gene therapy for HIV infection and AIDS
FI954580A7 (en) HIV protease inhibitors in pharmaceutical combinations for use in the treatment of AIDS
EP0624635A3 (en) Medical pressure-sensitive adhesive and medical bandage formed using the same.
FI956014L (en) Use of nona- and decapeptides for the preparation of a medicament for the treatment of AIDS
FI891716A7 (en) HIV protease inhibitors, which are useful in the treatment of AIDS
FI981591L (en) HIV protease inhibitors useful in the treatment of AIDS
AU8918998A (en) Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection
FI935777A7 (en) HIV protease inhibitors useful in the treatment of AIDS
NO941983D0 (en) Disposable syringes
FI965204A7 (en) Medicinal uses of bromelain
FI960850A7 (en) Use of quinoxalines in combination with protease inhibitors as a drug for the treatment of AIDS and/or HIV infections
KR950703360A (en) THERAPUTIC AGENT FROM MYCOBACTERRIUM VACCAE AND ITS USE AGAINST HIV INFECTION
PT983271E (en) NUCLEOSIDIC CARBOCYCLIC HEMISSULPHATE AND THEIR USE IN THE TREATMENT OF VIRAL INFECTIONS
FI932847A0 (en) HIV proteasinhibitors are used in the treatment of AIDS
EE03514B1 (en) A combination of compounds for the treatment of HIV infection or AIDS, its use and a pharmaceutical composition
FR2772621B1 (en) RETRACTABLE AND DISPOSABLE SAFETY SYRINGE
FI963263A0 (en) Medical use of bromelain
FI965196L (en) Combination therapy for HIV infection
KR950008188U (en) Disposable syringe
GB9508300D0 (en) HIV protease inhibtors for the treatment of aids
AU2002351176A1 (en) Peptides and use thereof in therapeutic agents against hiv infection
KR950026318U (en) Disposable Collar and Cufflinks